Calcium D-Glucarate vs NR (Nicotinamide Riboside)

Mechanism

Calcium D-glucarate is the calcium salt of D-glucaric acid, which is metabolized to D-glucaro-1,4-lactone (the active metabolite). This lactone inhibits beta-glucuronidase, the bacterial enzyme in the gut that deconjugates (cleaves) glucuronide conjugates from Phase II detoxification. By inhibiting beta-glucuronidase, calcium D-glucarate prevents the reabsorption (enterohepatic recirculation) of estrogen, environmental toxins, and carcinogens that were already conjugated for excretion. This effectively enhances the elimination of glucuronidated compounds, including estrogen metabolites, bilirubin, and xenobiotics.

Standard Dosing

500-1500mg daily

Timing

With meals, split 2-3x/day for sustained beta-glucuronidase inhibition.

Cycle Duration

ongoing or cycle with DIM protocol

Side Effects

• GI discomfort
• Loose stools
• Generally very well tolerated

Contraindications

• Pregnancy/lactation (estrogen clearance effects)
• Concurrent medications with narrow therapeutic index that undergo glucuronidation

Best Stacking Partners

Mechanism

NR is converted to NMN by nicotinamide riboside kinases (NRK1/NRK2), then to NAD+ via the salvage pathway. Like NMN, elevated NAD+ activates sirtuins, PARPs, and CD38. NR has demonstrated ability to cross the blood-brain barrier and elevate brain NAD+ levels. It supports mitochondrial function, DNA repair, and circadian rhythm regulation through SIRT1-mediated deacetylation of BMAL1 and CLOCK proteins.

Standard Dosing

300-600mg daily

Timing

Morning with or without food.

Cycle Duration

ongoing

Side Effects

• Mild nausea
• Warmth/flushing (mild)
• GI upset
• Fatigue in some during initial days

Contraindications

• Active cancer (same theoretical NAD+ concern as NMN)
• Pregnancy/lactation
• Theoretical cancer concern shared with NMN

Best Stacking Partners